nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—CYP3A4—Temozolomide—malignant glioma	0.103	1	CbGbCtD
Olopatadine—S100B—vertebral column—malignant glioma	0.0737	0.229	CbGeAlD
Olopatadine—S100B—blood vessel—malignant glioma	0.0302	0.0938	CbGeAlD
Olopatadine—S100A1—telencephalon—malignant glioma	0.017	0.0527	CbGeAlD
Olopatadine—S100B—brainstem—malignant glioma	0.0165	0.0513	CbGeAlD
Olopatadine—S100B—retina—malignant glioma	0.016	0.0495	CbGeAlD
Olopatadine—S100B—telencephalon—malignant glioma	0.0147	0.0455	CbGeAlD
Olopatadine—S100A1—medulla oblongata—malignant glioma	0.0133	0.0414	CbGeAlD
Olopatadine—S100A1—midbrain—malignant glioma	0.0122	0.0378	CbGeAlD
Olopatadine—S100A1—spinal cord—malignant glioma	0.0119	0.0369	CbGeAlD
Olopatadine—Hyperaemia—Carmustine—malignant glioma	0.0119	0.0961	CcSEcCtD
Olopatadine—S100B—midbrain—malignant glioma	0.0105	0.0327	CbGeAlD
Olopatadine—S100B—spinal cord—malignant glioma	0.0103	0.0319	CbGeAlD
Olopatadine—S100A1—central nervous system—malignant glioma	0.00966	0.0299	CbGeAlD
Olopatadine—S100A1—cerebellum—malignant glioma	0.00944	0.0293	CbGeAlD
Olopatadine—S100A13—central nervous system—malignant glioma	0.00857	0.0266	CbGeAlD
Olopatadine—S100A13—cerebellum—malignant glioma	0.00837	0.026	CbGeAlD
Olopatadine—S100B—central nervous system—malignant glioma	0.00834	0.0259	CbGeAlD
Olopatadine—S100A2—brain—malignant glioma	0.00832	0.0258	CbGeAlD
Olopatadine—S100B—cerebellum—malignant glioma	0.00815	0.0253	CbGeAlD
Olopatadine—S100A1—brain—malignant glioma	0.00767	0.0238	CbGeAlD
Olopatadine—S100A13—brain—malignant glioma	0.0068	0.0211	CbGeAlD
Olopatadine—S100A12—brain—malignant glioma	0.00671	0.0208	CbGeAlD
Olopatadine—S100B—brain—malignant glioma	0.00662	0.0205	CbGeAlD
Olopatadine—Visual acuity reduced—Temozolomide—malignant glioma	0.00584	0.0471	CcSEcCtD
Olopatadine—Amitriptyline—NTRK2—malignant glioma	0.00424	0.286	CrCbGaD
Olopatadine—Dry eye—Temozolomide—malignant glioma	0.00321	0.0259	CcSEcCtD
Olopatadine—HRH1—telencephalon—malignant glioma	0.00301	0.00933	CbGeAlD
Olopatadine—Eye pain—Carmustine—malignant glioma	0.00289	0.0233	CcSEcCtD
Olopatadine—Eye pain—Temozolomide—malignant glioma	0.00279	0.0225	CcSEcCtD
Olopatadine—Thirst—Temozolomide—malignant glioma	0.00265	0.0214	CcSEcCtD
Olopatadine—Amitriptyline—NTRK1—malignant glioma	0.00262	0.177	CrCbGaD
Olopatadine—Dry skin—Temozolomide—malignant glioma	0.00231	0.0187	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00202	0.0163	CcSEcCtD
Olopatadine—Clomipramine—GSTP1—malignant glioma	0.00201	0.136	CrCbGaD
Olopatadine—Depression—Carmustine—malignant glioma	0.002	0.0162	CcSEcCtD
Olopatadine—Weight increased—Temozolomide—malignant glioma	0.00198	0.016	CcSEcCtD
Olopatadine—Urinary tract infection—Carmustine—malignant glioma	0.00195	0.0158	CcSEcCtD
Olopatadine—Infestation NOS—Temozolomide—malignant glioma	0.00194	0.0157	CcSEcCtD
Olopatadine—Infestation—Temozolomide—malignant glioma	0.00194	0.0157	CcSEcCtD
Olopatadine—Depression—Temozolomide—malignant glioma	0.00194	0.0156	CcSEcCtD
Olopatadine—Urinary tract infection—Temozolomide—malignant glioma	0.00189	0.0152	CcSEcCtD
Olopatadine—Sinusitis—Temozolomide—malignant glioma	0.00182	0.0147	CcSEcCtD
Olopatadine—Hypoaesthesia—Carmustine—malignant glioma	0.0018	0.0145	CcSEcCtD
Olopatadine—Visual impairment—Carmustine—malignant glioma	0.00174	0.014	CcSEcCtD
Olopatadine—Hypoaesthesia—Temozolomide—malignant glioma	0.00174	0.014	CcSEcCtD
Olopatadine—Pharyngitis—Temozolomide—malignant glioma	0.00173	0.014	CcSEcCtD
Olopatadine—HRH1—central nervous system—malignant glioma	0.00171	0.00531	CbGeAlD
Olopatadine—Eye disorder—Carmustine—malignant glioma	0.00169	0.0136	CcSEcCtD
Olopatadine—Visual impairment—Temozolomide—malignant glioma	0.00168	0.0136	CcSEcCtD
Olopatadine—Eye disorder—Temozolomide—malignant glioma	0.00163	0.0132	CcSEcCtD
Olopatadine—Immune system disorder—Temozolomide—malignant glioma	0.00158	0.0127	CcSEcCtD
Olopatadine—Mediastinal disorder—Temozolomide—malignant glioma	0.00157	0.0127	CcSEcCtD
Olopatadine—Erythema—Carmustine—malignant glioma	0.00157	0.0127	CcSEcCtD
Olopatadine—Imipramine—CYP2C18—malignant glioma	0.00156	0.105	CrCbGaD
Olopatadine—Back pain—Carmustine—malignant glioma	0.00152	0.0123	CcSEcCtD
Olopatadine—Erythema—Temozolomide—malignant glioma	0.00152	0.0123	CcSEcCtD
Olopatadine—Dysgeusia—Temozolomide—malignant glioma	0.00149	0.012	CcSEcCtD
Olopatadine—Vision blurred—Carmustine—malignant glioma	0.00148	0.012	CcSEcCtD
Olopatadine—Back pain—Temozolomide—malignant glioma	0.00147	0.0119	CcSEcCtD
Olopatadine—Vision blurred—Temozolomide—malignant glioma	0.00143	0.0115	CcSEcCtD
Olopatadine—Ill-defined disorder—Temozolomide—malignant glioma	0.00141	0.0114	CcSEcCtD
Olopatadine—Malaise—Temozolomide—malignant glioma	0.00137	0.0111	CcSEcCtD
Olopatadine—HRH1—brain—malignant glioma	0.00136	0.00421	CbGeAlD
Olopatadine—Cough—Temozolomide—malignant glioma	0.00132	0.0107	CcSEcCtD
Olopatadine—CYP3A4—central nervous system—malignant glioma	0.00132	0.0041	CbGeAlD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00128	0.0104	CcSEcCtD
Olopatadine—Oedema—Carmustine—malignant glioma	0.00128	0.0103	CcSEcCtD
Olopatadine—Discomfort—Temozolomide—malignant glioma	0.00128	0.0103	CcSEcCtD
Olopatadine—Infection—Carmustine—malignant glioma	0.00127	0.0103	CcSEcCtD
Olopatadine—Dry mouth—Temozolomide—malignant glioma	0.00126	0.0102	CcSEcCtD
Olopatadine—Oedema—Temozolomide—malignant glioma	0.00124	0.01	CcSEcCtD
Olopatadine—Infection—Temozolomide—malignant glioma	0.00123	0.00994	CcSEcCtD
Olopatadine—Nervous system disorder—Temozolomide—malignant glioma	0.00122	0.00981	CcSEcCtD
Olopatadine—Skin disorder—Temozolomide—malignant glioma	0.0012	0.00971	CcSEcCtD
Olopatadine—Imipramine—CYP2B6—malignant glioma	0.00115	0.078	CrCbGaD
Olopatadine—Amitriptyline—CYP2B6—malignant glioma	0.00115	0.0775	CrCbGaD
Olopatadine—Dyspnoea—Carmustine—malignant glioma	0.00114	0.00923	CcSEcCtD
Olopatadine—Somnolence—Carmustine—malignant glioma	0.00114	0.0092	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00111	0.00894	CcSEcCtD
Olopatadine—Dyspnoea—Temozolomide—malignant glioma	0.0011	0.00892	CcSEcCtD
Olopatadine—Somnolence—Temozolomide—malignant glioma	0.0011	0.00889	CcSEcCtD
Olopatadine—Pain—Carmustine—malignant glioma	0.0011	0.00885	CcSEcCtD
Olopatadine—Nortriptyline—PTGS1—malignant glioma	0.00109	0.0735	CrCbGaD
Olopatadine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00107	0.00863	CcSEcCtD
Olopatadine—Fatigue—Temozolomide—malignant glioma	0.00107	0.00862	CcSEcCtD
Olopatadine—Pain—Temozolomide—malignant glioma	0.00106	0.00855	CcSEcCtD
Olopatadine—Feeling abnormal—Carmustine—malignant glioma	0.00106	0.00853	CcSEcCtD
Olopatadine—Gastrointestinal pain—Carmustine—malignant glioma	0.00105	0.00846	CcSEcCtD
Olopatadine—Feeling abnormal—Temozolomide—malignant glioma	0.00102	0.00824	CcSEcCtD
Olopatadine—Abdominal pain—Carmustine—malignant glioma	0.00101	0.00818	CcSEcCtD
Olopatadine—Body temperature increased—Carmustine—malignant glioma	0.00101	0.00818	CcSEcCtD
Olopatadine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00101	0.00818	CcSEcCtD
Olopatadine—Imipramine—SLC6A3—malignant glioma	0.000984	0.0665	CrCbGaD
Olopatadine—Abdominal pain—Temozolomide—malignant glioma	0.000979	0.00791	CcSEcCtD
Olopatadine—Body temperature increased—Temozolomide—malignant glioma	0.000979	0.00791	CcSEcCtD
Olopatadine—Hypersensitivity—Carmustine—malignant glioma	0.000945	0.00763	CcSEcCtD
Olopatadine—Asthenia—Carmustine—malignant glioma	0.00092	0.00743	CcSEcCtD
Olopatadine—Hypersensitivity—Temozolomide—malignant glioma	0.000913	0.00737	CcSEcCtD
Olopatadine—Asthenia—Temozolomide—malignant glioma	0.000889	0.00718	CcSEcCtD
Olopatadine—Diarrhoea—Carmustine—malignant glioma	0.000877	0.00708	CcSEcCtD
Olopatadine—Pruritus—Temozolomide—malignant glioma	0.000877	0.00708	CcSEcCtD
Olopatadine—Dizziness—Carmustine—malignant glioma	0.000848	0.00684	CcSEcCtD
Olopatadine—Diarrhoea—Temozolomide—malignant glioma	0.000848	0.00684	CcSEcCtD
Olopatadine—Dizziness—Temozolomide—malignant glioma	0.000819	0.00661	CcSEcCtD
Olopatadine—Vomiting—Carmustine—malignant glioma	0.000815	0.00658	CcSEcCtD
Olopatadine—Rash—Carmustine—malignant glioma	0.000808	0.00653	CcSEcCtD
Olopatadine—Dermatitis—Carmustine—malignant glioma	0.000808	0.00652	CcSEcCtD
Olopatadine—Headache—Carmustine—malignant glioma	0.000803	0.00648	CcSEcCtD
Olopatadine—Vomiting—Temozolomide—malignant glioma	0.000788	0.00636	CcSEcCtD
Olopatadine—Rash—Temozolomide—malignant glioma	0.000781	0.00631	CcSEcCtD
Olopatadine—Dermatitis—Temozolomide—malignant glioma	0.00078	0.0063	CcSEcCtD
Olopatadine—Headache—Temozolomide—malignant glioma	0.000776	0.00627	CcSEcCtD
Olopatadine—Nausea—Carmustine—malignant glioma	0.000762	0.00615	CcSEcCtD
Olopatadine—Nausea—Temozolomide—malignant glioma	0.000736	0.00594	CcSEcCtD
Olopatadine—HRH1—IL-4 Signaling Pathway—AKT1—malignant glioma	0.000233	0.000535	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FLT1—malignant glioma	0.000233	0.000535	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—DUSP6—malignant glioma	0.000232	0.000533	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—PTEN—malignant glioma	0.00023	0.000529	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—JAG1—malignant glioma	0.000229	0.000526	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOTCH3—malignant glioma	0.000228	0.000524	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-A—malignant glioma	0.000227	0.000522	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FBXW7—malignant glioma	0.000224	0.000515	CbGpPWpGaD
Olopatadine—S100B—Immune System—PDGFB—malignant glioma	0.000222	0.000509	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCR3—malignant glioma	0.000222	0.000509	CbGpPWpGaD
Olopatadine—S100B—Immune System—FGFR1—malignant glioma	0.000221	0.000507	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—BDKRB2—malignant glioma	0.00022	0.000505	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PTEN—malignant glioma	0.000218	0.0005	CbGpPWpGaD
Olopatadine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000213	0.000488	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	0.000211	0.000485	CbGpPWpGaD
Olopatadine—S100A12—Immune System—BAD—malignant glioma	0.000209	0.00048	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOTCH2—malignant glioma	0.000205	0.00047	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD80—malignant glioma	0.000203	0.000466	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—BDKRB2—malignant glioma	0.000203	0.000465	CbGpPWpGaD
Olopatadine—S100A12—Immune System—EGF—malignant glioma	0.0002	0.00046	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KNG1—malignant glioma	0.0002	0.00046	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PTPN11—malignant glioma	0.000199	0.000457	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.000199	0.000456	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000199	0.000456	CbGpPWpGaD
Olopatadine—S100B—Immune System—BAD—malignant glioma	0.000198	0.000454	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LATS1—malignant glioma	0.000193	0.000443	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD80—malignant glioma	0.000192	0.000441	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NTRK1—malignant glioma	0.000191	0.000438	CbGpPWpGaD
Olopatadine—S100B—Immune System—EGF—malignant glioma	0.000189	0.000435	CbGpPWpGaD
Olopatadine—S100B—Immune System—PTPN11—malignant glioma	0.000188	0.000432	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—EGFR—malignant glioma	0.000187	0.00043	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000186	0.000427	CbGpPWpGaD
Olopatadine—S100A12—Immune System—AKT2—malignant glioma	0.000185	0.000425	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—KNG1—malignant glioma	0.000184	0.000423	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PIK3CD—malignant glioma	0.000178	0.000409	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MMP3—malignant glioma	0.000177	0.000407	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—EGFR—malignant glioma	0.000177	0.000406	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—KRAS—malignant glioma	0.000177	0.000406	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CDKN2B—malignant glioma	0.000176	0.000404	CbGpPWpGaD
Olopatadine—S100B—Immune System—AKT2—malignant glioma	0.000175	0.000402	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PTK2—malignant glioma	0.000171	0.000392	CbGpPWpGaD
Olopatadine—S100A12—Immune System—FGF2—malignant glioma	0.000171	0.000391	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR4—malignant glioma	0.000169	0.000387	CbGpPWpGaD
Olopatadine—S100B—Immune System—PIK3CD—malignant glioma	0.000168	0.000387	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HES1—malignant glioma	0.000168	0.000385	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—KRAS—malignant glioma	0.000167	0.000384	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NCOR1—malignant glioma	0.000167	0.000383	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—PIK3CA—malignant glioma	0.000162	0.000373	CbGpPWpGaD
Olopatadine—S100A12—Immune System—BCL2—malignant glioma	0.000162	0.000372	CbGpPWpGaD
Olopatadine—S100B—Immune System—FGF2—malignant glioma	0.000161	0.00037	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNG—malignant glioma	0.00016	0.000368	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PDGFRA—malignant glioma	0.00016	0.000367	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MDM2—malignant glioma	0.00016	0.000366	CbGpPWpGaD
Olopatadine—S100A12—Immune System—RAF1—malignant glioma	0.000159	0.000365	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.000159	0.000365	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ERBB2—malignant glioma	0.000157	0.000361	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000157	0.000359	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PIK3CB—malignant glioma	0.000155	0.000356	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SPP1—malignant glioma	0.000155	0.000356	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PIK3CA—malignant glioma	0.000154	0.000353	CbGpPWpGaD
Olopatadine—S100B—Immune System—BCL2—malignant glioma	0.000153	0.000351	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR4—malignant glioma	0.000153	0.000351	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNG—malignant glioma	0.000152	0.000348	CbGpPWpGaD
Olopatadine—S100B—Immune System—MDM2—malignant glioma	0.000151	0.000346	CbGpPWpGaD
Olopatadine—S100B—Immune System—RAF1—malignant glioma	0.00015	0.000345	CbGpPWpGaD
Olopatadine—S100B—Immune System—ERBB2—malignant glioma	0.000149	0.000341	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TERT—malignant glioma	0.000147	0.000337	CbGpPWpGaD
Olopatadine—S100B—Immune System—PIK3CB—malignant glioma	0.000147	0.000337	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PDGFB—malignant glioma	0.000143	0.000329	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1B—malignant glioma	0.000143	0.000328	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FGFR1—malignant glioma	0.000143	0.000328	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL2—malignant glioma	0.000143	0.000327	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HIF1A—malignant glioma	0.000141	0.000323	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000139	0.00032	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000138	0.000316	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CAV1—malignant glioma	0.000136	0.000312	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000136	0.000312	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL1B—malignant glioma	0.000135	0.000311	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL2—malignant glioma	0.000135	0.000309	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KDR—malignant glioma	0.000134	0.000309	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PTEN—malignant glioma	0.000134	0.000308	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—AKT1—malignant glioma	0.000133	0.000305	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MDK—malignant glioma	0.00013	0.000299	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—F2—malignant glioma	0.000129	0.000297	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FN1—malignant glioma	0.000129	0.000297	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—BAD—malignant glioma	0.000128	0.000294	CbGpPWpGaD
Olopatadine—S100B—Immune System—PTEN—malignant glioma	0.000127	0.000291	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOTCH1—malignant glioma	0.000127	0.000291	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—AKT1—malignant glioma	0.000126	0.000288	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCR3—malignant glioma	0.000125	0.000288	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DTX1—malignant glioma	0.000124	0.000286	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CD80—malignant glioma	0.000124	0.000285	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APC—malignant glioma	0.000124	0.000284	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CG—malignant glioma	0.000124	0.000284	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EGF—malignant glioma	0.000122	0.000281	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PTPN11—malignant glioma	0.000122	0.000279	CbGpPWpGaD
Olopatadine—S100A12—Immune System—STAT3—malignant glioma	0.00012	0.000275	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—F2—malignant glioma	0.000119	0.000274	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—BRAF—malignant glioma	0.000116	0.000267	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—BDKRB2—malignant glioma	0.000115	0.000263	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCR3—malignant glioma	0.000114	0.000261	CbGpPWpGaD
Olopatadine—S100B—Immune System—STAT3—malignant glioma	0.000113	0.00026	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKT2—malignant glioma	0.000113	0.00026	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.00011	0.000253	CbGpPWpGaD
Olopatadine—S100A12—Immune System—EGFR—malignant glioma	0.000109	0.00025	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.000109	0.00025	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CD—malignant glioma	0.000109	0.00025	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—PIK3CA—malignant glioma	0.000106	0.000243	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FGF2—malignant glioma	0.000104	0.000239	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—KNG1—malignant glioma	0.000104	0.000239	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—BDKRB2—malignant glioma	0.000104	0.000239	CbGpPWpGaD
Olopatadine—S100B—Immune System—EGFR—malignant glioma	0.000103	0.000237	CbGpPWpGaD
Olopatadine—S100A12—Immune System—KRAS—malignant glioma	0.000103	0.000236	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.000103	0.000236	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SUFU—malignant glioma	9.89e-05	0.000227	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HEY2—malignant glioma	9.77e-05	0.000224	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MDM2—malignant glioma	9.75e-05	0.000224	CbGpPWpGaD
Olopatadine—S100B—Immune System—KRAS—malignant glioma	9.74e-05	0.000224	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RAF1—malignant glioma	9.72e-05	0.000223	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ERBB2—malignant glioma	9.62e-05	0.000221	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GFAP—malignant glioma	9.54e-05	0.000219	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CB—malignant glioma	9.49e-05	0.000218	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—KNG1—malignant glioma	9.47e-05	0.000217	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PIK3CA—malignant glioma	9.46e-05	0.000217	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	9.45e-05	0.000217	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SPHK1—malignant glioma	9.23e-05	0.000212	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCL8—malignant glioma	9.12e-05	0.000209	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HEY1—malignant glioma	9.04e-05	0.000208	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR4—malignant glioma	9.04e-05	0.000208	CbGpPWpGaD
Olopatadine—S100B—Immune System—PIK3CA—malignant glioma	8.95e-05	0.000205	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HIST1H3B—malignant glioma	8.79e-05	0.000202	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CASP3—malignant glioma	8.73e-05	0.0002	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL2—malignant glioma	8.72e-05	0.0002	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCL8—malignant glioma	8.4e-05	0.000193	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—MMP3—malignant glioma	8.39e-05	0.000193	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MMP9—malignant glioma	8.25e-05	0.000189	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PTEN—malignant glioma	8.2e-05	0.000188	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JAG2—malignant glioma	8.02e-05	0.000184	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—COX8A—malignant glioma	8e-05	0.000184	CbGpPWpGaD
Olopatadine—S100A12—Immune System—AKT1—malignant glioma	7.73e-05	0.000177	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—malignant glioma	7.41e-05	0.00017	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—STAT3—malignant glioma	7.33e-05	0.000168	CbGpPWpGaD
Olopatadine—S100B—Immune System—AKT1—malignant glioma	7.31e-05	0.000168	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MYC—malignant glioma	6.82e-05	0.000156	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ASMT—malignant glioma	6.8e-05	0.000156	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—H3F3A—malignant glioma	6.79e-05	0.000156	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—F2—malignant glioma	6.74e-05	0.000155	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCR3—malignant glioma	6.72e-05	0.000154	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EGFR—malignant glioma	6.67e-05	0.000153	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NTRK2—malignant glioma	6.54e-05	0.00015	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—YWHAE—malignant glioma	6.54e-05	0.00015	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FLT1—malignant glioma	6.51e-05	0.000149	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DUSP6—malignant glioma	6.48e-05	0.000149	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CG—malignant glioma	6.45e-05	0.000148	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JAG1—malignant glioma	6.4e-05	0.000147	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—BCAN—malignant glioma	6.39e-05	0.000147	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOTCH3—malignant glioma	6.37e-05	0.000146	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KRAS—malignant glioma	6.3e-05	0.000145	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FBXW7—malignant glioma	6.27e-05	0.000144	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—BDKRB2—malignant glioma	6.15e-05	0.000141	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—F2—malignant glioma	6.12e-05	0.00014	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKT2—malignant glioma	5.9e-05	0.000135	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CG—malignant glioma	5.86e-05	0.000134	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CA—malignant glioma	5.79e-05	0.000133	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PTPN11—malignant glioma	5.75e-05	0.000132	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOTCH2—malignant glioma	5.71e-05	0.000131	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CD—malignant glioma	5.67e-05	0.00013	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TP53—malignant glioma	5.6e-05	0.000128	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KNG1—malignant glioma	5.59e-05	0.000128	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKT2—malignant glioma	5.36e-05	0.000123	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NTRK1—malignant glioma	5.33e-05	0.000122	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—IDH2—malignant glioma	5.15e-05	0.000118	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CD—malignant glioma	5.15e-05	0.000118	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP3—malignant glioma	4.95e-05	0.000114	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CB—malignant glioma	4.94e-05	0.000113	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDKN2B—malignant glioma	4.91e-05	0.000113	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.85e-05	0.000111	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTK2—malignant glioma	4.77e-05	0.000109	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL8—malignant glioma	4.75e-05	0.000109	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKT1—malignant glioma	4.73e-05	0.000108	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HES1—malignant glioma	4.69e-05	0.000108	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NCOR1—malignant glioma	4.66e-05	0.000107	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—RAF1—malignant glioma	4.6e-05	0.000105	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL2—malignant glioma	4.54e-05	0.000104	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CB—malignant glioma	4.49e-05	0.000103	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PDGFRA—malignant glioma	4.46e-05	0.000102	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—IDH1—malignant glioma	4.43e-05	0.000102	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SPP1—malignant glioma	4.33e-05	9.94e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL8—malignant glioma	4.31e-05	9.9e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SPHK1—malignant glioma	4.29e-05	9.84e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.2e-05	9.64e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL2—malignant glioma	4.12e-05	9.46e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TERT—malignant glioma	4.11e-05	9.42e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PDGFB—malignant glioma	4.01e-05	9.2e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FGFR1—malignant glioma	3.99e-05	9.15e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HIF1A—malignant glioma	3.93e-05	9.01e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CAV1—malignant glioma	3.8e-05	8.72e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KDR—malignant glioma	3.76e-05	8.62e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—F2—malignant glioma	3.61e-05	8.3e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FN1—malignant glioma	3.61e-05	8.3e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—BAD—malignant glioma	3.57e-05	8.2e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOTCH1—malignant glioma	3.54e-05	8.12e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CD80—malignant glioma	3.47e-05	7.95e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APC—malignant glioma	3.46e-05	7.94e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CG—malignant glioma	3.46e-05	7.94e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EGF—malignant glioma	3.42e-05	7.85e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTPN11—malignant glioma	3.4e-05	7.8e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTT1—malignant glioma	3.4e-05	7.8e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—BRAF—malignant glioma	3.25e-05	7.46e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS1—malignant glioma	3.18e-05	7.31e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKT2—malignant glioma	3.16e-05	7.26e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EGFR—malignant glioma	3.15e-05	7.23e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CD—malignant glioma	3.04e-05	6.98e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	3.01e-05	6.91e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—KRAS—malignant glioma	2.98e-05	6.83e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—BCHE—malignant glioma	2.96e-05	6.79e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.92e-05	6.71e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FGF2—malignant glioma	2.91e-05	6.68e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	2.74e-05	6.28e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MDM2—malignant glioma	2.72e-05	6.25e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RAF1—malignant glioma	2.71e-05	6.23e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ERBB2—malignant glioma	2.69e-05	6.16e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	2.65e-05	6.08e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL8—malignant glioma	2.55e-05	5.85e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	2.46e-05	5.65e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CASP3—malignant glioma	2.44e-05	5.6e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL2—malignant glioma	2.43e-05	5.59e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTP1—malignant glioma	2.35e-05	5.41e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP9—malignant glioma	2.3e-05	5.29e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CAT—malignant glioma	2.29e-05	5.26e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTEN—malignant glioma	2.29e-05	5.26e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKT1—malignant glioma	2.23e-05	5.13e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NCOR1—malignant glioma	2.16e-05	4.97e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—malignant glioma	2.07e-05	4.75e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—STAT3—malignant glioma	2.05e-05	4.7e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MYC—malignant glioma	1.9e-05	4.37e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EGFR—malignant glioma	1.86e-05	4.27e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CAV1—malignant glioma	1.76e-05	4.05e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KRAS—malignant glioma	1.76e-05	4.04e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	1.62e-05	3.71e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.61e-05	3.69e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TP53—malignant glioma	1.56e-05	3.59e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARG—malignant glioma	1.55e-05	3.56e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.41e-05	3.24e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKT1—malignant glioma	1.32e-05	3.03e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.23e-05	2.83e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.22e-05	2.8e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTEN—malignant glioma	1.06e-05	2.44e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.51e-06	1.72e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKT1—malignant glioma	6.13e-06	1.41e-05	CbGpPWpGaD
